{"id":134475,"date":"2022-09-30T06:05:50","date_gmt":"2022-09-30T10:05:50","guid":{"rendered":"https:\/\/44.250.171.167\/?p=134475"},"modified":"2022-10-06T04:56:04","modified_gmt":"2022-10-06T08:56:04","slug":"panacea-biotech-q1fy23-net-profit-soars-by-2","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/panacea-biotech-q1fy23-net-profit-soars-by-2\/","title":{"rendered":"Panacea Biotech Q1FY23 Net profit soars by 2%"},"content":{"rendered":"\n<p><a href=\"https:\/\/44.250.171.167\/symbol\/panaceabiotech\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"Panacea Biotec\">Panacea Biotec<\/a> reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores during the period ended June 30, 2021 thereby depicting a dip of 16% on consolidated basis. While the net profit grew by 2% from INR -57.35 crores for the period ended June 30, 2021 to INR -56.14 crores for the period ended June 30, 2022. The decline in revenues is mainly on account of absence of sales of pharmaceutical formulations which contributed INR 49.38 Crores during Q1FY23.<\/p>\n\n\n\n<p>Meanwhile, the company has reported EPS of Rs.-9.17 for the period ended June 30, 2022 as compared to Rs.-9.36 for the period ended June 30, 2021. The vaccines constituted 55.4% of the total revenues while the formulations accounted for 44.6%. Also sudden spike in material cost led to such plummet in net profits of the company. After resolving its debt and reinstating the capital in its development, the company is on its track to lead the pharma sector in India.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-style-default\"><img loading=\"lazy\" decoding=\"async\" width=\"918\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-918x1024.jpg\" alt=\"\" class=\"wp-image-134476\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-918x1024.jpg 918w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-269x300.jpg 269w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-768x857.jpg 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-1376x1536.jpg 1376w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/09\/Panacea-IG-1835x2048.jpg 1835w\" sizes=\"auto, (max-width: 918px) 100vw, 918px\" \/><\/figure>\n\n\n\n<p>To know more about about Panacea Biotech in brief: <a href=\"https:\/\/44.250.171.167\/decoding-panacea-biotec-limited-indias-leading-vaccine-developer\/\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores during the period ended June 30, 2021 thereby depicting a dip of 16% on consolidated basis. While the net profit grew by 2% from INR -57.35 crores for the period ended June 30, [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":49407,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10155,1115,10439],"class_list":["post-134475","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-biosimilars","tag-pharmaceuticals","tag-vaccine"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":136932,"url":"https:\/\/alphastreet.com\/india\/care-ratings-reported-22-rise-in-its-net-profit-for-q1fy23\/","url_meta":{"origin":134475,"position":0},"title":"CARE Ratings reported 22% rise in its net profit for Q1 FY23","author":"Chirag Gupta","date":"July 17, 2022","format":false,"excerpt":"CARE Ratings reported total income of INR 62.09 crores during the period ended June 30, 2022 as compared to INR 56.52 crores during the period ended June 30, 2021 which was up by 10%. The company has posted net profit of INR 13.66 crores for the period ended June 30,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":134481,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-reports-dip-in-its-net-profit-by-71-for-q1fy23\/","url_meta":{"origin":134475,"position":1},"title":"Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23","author":"Chirag Gupta","date":"October 3, 2022","format":false,"excerpt":"Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR 1,635 crores during the period ended June 30, 2021 depicting a dip of 11% while the net profit further plummeted by 71% as the company posted net profit INR 47\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":133811,"url":"https:\/\/alphastreet.com\/india\/infographic-pnb-housing-finance-q1-net-profit-down-by-3\/","url_meta":{"origin":134475,"position":2},"title":"Infographic: PNB Housing Finance Q1 net profit down by 3%","author":"Chirag Gupta","date":"July 28, 2022","format":false,"excerpt":"PNB Housing finance reported total income of INR 1411 crores during the period ended June 30, 2022 as compared to INR 1425 crores during the period ended March 31, 2022. The company reported a dip in its revenue by 0.97% and 16.59% on QoQ and YoY basis subsequently. The company\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":142665,"url":"https:\/\/alphastreet.com\/india\/westlife-foodworld-q3fy23-net-profit-rises-by-75-percent\/","url_meta":{"origin":134475,"position":3},"title":"Westlife Foodworld Q3FY23 net profit rises by 75 percent","author":"Chirag Gupta","date":"February 23, 2023","format":false,"excerpt":"Westlife Foodworld reported total income of INR 619.20 crores during the period ended December 31, 2022 as compared to INR 481.09 crores during the period ended December 31, 2021 depicting a growth of 29%. Meanwhile, the company has posted net profit of INR 36.37 crores for the period ended December\u2026","rel":"","context":"In &quot;Consumer&quot;","block_context":{"text":"Consumer","link":"https:\/\/alphastreet.com\/india\/category\/consumer-stocks\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":142650,"url":"https:\/\/alphastreet.com\/india\/varroc-engineering-q3fy23-net-profit-rises-by-107\/","url_meta":{"origin":134475,"position":4},"title":"Varroc Engineering Q3FY23 net profit rises by 107%","author":"Chirag Gupta","date":"February 23, 2023","format":false,"excerpt":"Varroc Engineering reported total income of INR 1725.78 crores during the period ended December 31, 2022 as compared to INR 1497.103 crores during the period ended December 31, 2021 depicting a growth of 15.2%. Meanwhile, the company has posted net profit of INR 20.40 crores for the period ended December\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":142946,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-q3fy23-net-profit-drops-by-33-percent\/","url_meta":{"origin":134475,"position":5},"title":"Suven pharmaceuticals Q3FY23 net profit drops by 33 percent","author":"Chirag Gupta","date":"February 28, 2023","format":false,"excerpt":"The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to INR 456.27 crores during the period ended December 31, 2021, depicting a fall of 19.6%. The company has posted net profit of INR 107.72 crores for the period ended December\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/134475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=134475"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/134475\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/49407"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=134475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=134475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=134475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}